Doctor Jiawen Li

Doctor Jiawen Li

Beijing (China)

Born in 1997, Li Jiawen is a postgraduate of Fuwai hospital in China. She is the first student of Professor Zhao Xueyan with research direction of inflammation and biomarkers in coronary artery disease.

Presentations

Remnant cholesterol is associated with platelet reactivity for patients with coronary artery disease underwent percutaneous coronary intervention

Event: ESC Congress 2024

Topic: Biomarkers

Session: Novel biomarkers for cardiovascular risk prediction

Access

ABO blood groups and platelet reactivity in patients with coronary artery disease undergoing percutaneous coronary intervention treated with clopidogrel

Event: ESC Congress 2024

Topic: Biomarkers

Session: Cancer and other risk factors for heart disease

Access

Low-density lipoprotein cholesterol levels and long-term bleeding in patients undergoing percutaneous coronary intervention: 5-year outcomes from a large cohort study

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Coronary artery disease - Epidemiology, prognosis, outcome 5

Access

Different inflammatory markers reflect different platelet reactivties in percutaneous coronary intervention patients treated with clopidogrel: a large sample study from China

Event: ESC Congress 2021 - The Digital Experience

Topic: Inflammation

Session: Acute Coronary Syndromes ePosters

Access

Association between NPC1L1 and HMGCR gene polymorphisms with residual cholesterol risk in patients with premature triple-vessel disease

Event: ESC Congress 2021 - The Digital Experience

Topic: Genetics, Epigenetics, ncRNA

Session: Basic science e-posters

Access

Correlation between NCP1L1 and HMGCR Gene Polymorphism and Major Adverse Cardiac and Cerebrovascular Events in Patients with Three-Vessel Disease

Event: ESC Congress 2020

Topic: Ischaemia, Infarction, Cardioprotection

Session: Molecular Mechanisms that Modulate Ischemia Injury

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Jiawen Li

Biography

Contributor content

Remnant cholesterol is associated with platelet reactivity for patients with coronary artery disease underwent percutaneous coronary intervention

ABO blood groups and platelet reactivity in patients with coronary artery disease undergoing percutaneous coronary intervention treated with clopidogrel

Low-density lipoprotein cholesterol levels and long-term bleeding in patients undergoing percutaneous coronary intervention: 5-year outcomes from a large cohort study

Different inflammatory markers reflect different platelet reactivties in percutaneous coronary intervention patients treated with clopidogrel: a large sample study from China

Association between NPC1L1 and HMGCR gene polymorphisms with residual cholesterol risk in patients with premature triple-vessel disease

Correlation between NCP1L1 and HMGCR Gene Polymorphism and Major Adverse Cardiac and Cerebrovascular Events in Patients with Three-Vessel Disease

ESC 365 is supported by

Doctor Jiawen Li Follow

Biography

Contributor content

Remnant cholesterol is associated with platelet reactivity for patients with coronary artery disease underwent percutaneous coronary intervention

ABO blood groups and platelet reactivity in patients with coronary artery disease undergoing percutaneous coronary intervention treated with clopidogrel

Low-density lipoprotein cholesterol levels and long-term bleeding in patients undergoing percutaneous coronary intervention: 5-year outcomes from a large cohort study

Different inflammatory markers reflect different platelet reactivties in percutaneous coronary intervention patients treated with clopidogrel: a large sample study from China

Association between NPC1L1 and HMGCR gene polymorphisms with residual cholesterol risk in patients with premature triple-vessel disease

Correlation between NCP1L1 and HMGCR Gene Polymorphism and Major Adverse Cardiac and Cerebrovascular Events in Patients with Three-Vessel Disease

ESC 365 is supported by

Doctor Jiawen Li